Immunogenicity Assessment of Different Segments and Domains of Group a Streptococcal C5a Peptidase and Their Application Potential as Carrier Protein for Glycoconjugate Vaccine Development

被引:6
|
作者
Wang, Guirong
Zhao, Jielin
Zhao, Yisheng
Wang, Subo
Feng, Shaojie
Gu, Guofeng [1 ]
机构
[1] Shandong Univ, Natl Glycoengn Res Ctr, 72 Binhai Rd, Qingdao 266237, Peoples R China
基金
中国国家自然科学基金;
关键词
group A streptococcus; group A streptococcal C5a peptidase; subunit protein vaccine; immunogenicity; carrier protein;
D O I
10.3390/vaccines9020139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group A streptococcal C5a peptidase (ScpA) is a highly conserved surface virulence factor present on group A streptococcus (GAS) cell surfaces. It has attracted much more attention as a promising antigenic target for GAS vaccine development due to its high antigenicity to stimulate specific and immunoprotective antibodies. In this study, a series of segments of ScpA were rationally designed according to the functional domains described in its crystal structure, efficiently prepared and immunologically evaluated so as to assess their potential as antigens for the development of subunit vaccines. Immunological studies revealed that Fn, Fn2, and rsScpA193 proteins were promising antigen candidates worthy for further exploration. In addition, the potential of Fn and Fn2 as carrier proteins to formulate effective glycoconjugate vaccine was also investigated.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 3 条
  • [1] Mutagenesis and immunological evaluation of group A streptococcal C5a peptidase as an antigen for vaccine development and as a carrier protein for glycoconjugate vaccine design
    Li, Hui
    Wang, Subo
    Zhao, Yisheng
    Chen, Zonggang
    Gu, Guofeng
    Guo, Zhongwu
    RSC ADVANCES, 2017, 7 (67): : 42056 - 42063
  • [2] Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections
    Shet, A
    Kaplan, E
    Johnson, D
    Cleary, PP
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 119 : 95 - 98
  • [3] The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B Streptococcus Infection via Cross-Reactive IgG Targeting Virulence Factor C5a Peptidase
    McCabe, Sinead
    Bjanes, Elisabet
    Hendriks, Astrid
    Wang, Zhen
    van Sorge, Nina M.
    Pill-Pepe, Lucy
    Bautista, Leslie
    Chu, Ellen
    Codee, Jeroen D. C.
    Fairman, Jeff
    Kapoor, Neeraj
    Uchiyama, Satoshi
    Nizet, Victor
    VACCINES, 2023, 11 (12)